Position in ABEO
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$2,340,553
-$405,574 QoQ
Shares Held
522,445
+0.3% QoQ
Ownership
0.917%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABEO Over Time
Shares Held
Position Value (USD)
Derivatives in ABEO
reported options exposure · as of Jun 30, 2024CallValue
$296,800
CallShares
70,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026CITIGROUP INC holds $1,427,808,560 across 402 Biotechnology names. ABEO ranks #58 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
682,807 | $304,900,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
184,691 | $142,699,654 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
263,375 | $87,142,884 | |
| 4 | MRNA |
Moderna, Inc.
|
1,480,034 | $75,185,727 | |
| 5 | FOLD |
AMICUS THERAPEUTICS, INC.
|
4,226,882 | $61,120,713 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
746,483 | $55,433,827 | |
| 7 | INCY |
Incyte Corp
|
489,649 | $46,085,763 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,536,110 | $42,550,246 |
All Filings in ABEO
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,340,553 | 522,445 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $2,746,127 | 521,087 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,766,485 | 523,956 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $3,112,963 | 548,057 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $2,511,176 | 527,558 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $3,418,425 | 613,721 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $3,897,341 | 616,668 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $296,800 | 70,000 | Call | Defined | 2024-08-12 | |
| 2024-06-30 | $2,079,024 | 490,336 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $3,509,391 | 484,054 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $2,256,238 | 450,347 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,894,500 | 450,000 | Shares | Defined | 2023-12-06 | |
| 2023-06-30 | $806,000 | 200,000 | Shares | Defined | 2023-08-10 | |
| No filing history on record for this holder in this stock. | ||||||